Identification of a specific amino acid cluster in the calmodulin-binding domain of the neuronal nitric oxide synthase  by Watanabe, Yasuo et al.
FEBS 18157 FEBS Letters 403 (1997) 75-78 
Identification of a specific amino acid cluster in the calmodulin-binding 
domain of the neuronal nitric oxide synthase 
Yasuo Watanabe, Yu Hu, Hiroyoshi Hidaka* 
Department of Pharmacology, Nagoya University School of Medicine, Showa-ku, Nagoya 466, Japan 
Received 13 December 1996 
Abstract The calmodulin (CaM) binding domain of rat 
neuronal nitric oxide synthase (nNOS) was analyzed using 
3 synthetic peptides corresponding to different regions of the 
middle portion of the enzyme. One corresponding to nNOS 732-
754 gave complete inhibition of N O S enzyme activity with an 
IC50 of about 1 (iM. Kinetic analysis indicated that the inhibition 
was not competitive with respect to L-arginine and the peptide 
produced a Ca2 + dependent, electrophoretic mobility shift of 
CaM on 1 M urea gels. A specific hydrophobic/basic amino acid 
cluster in the rat nNOS sequence, Lys732LysLeu, that was 
critical for its CaM binding was also identified in this study. 
© 1997 Federation of European Biochemical Societes. 
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1. Introduction 
Nitric oxide synthases (NOSs) catalyze the oxidation of L-
arginine to form L-citrulline and nitric oxide (NO), a ubiqui-
tous paracrine substance with diverse physiological roles [1]. 
The activity of the constitutive neuronal N O S (nNOS) [2,3] 
and endothelial NOS (eNOS) [4,5] is Ca2+/calmodulin (CaM) 
dependent. There is also an inducible N O S (iNOS) [6,7] which 
is a Ca 2 + insensitive enzyme containing C a M as a tightly 
bound subunit. For enzyme regulation of NOSs, there are 
at least two important points to consider in terms of structure 
and function. First, there is the C a M binding domain, iden-
tified as the amino acid sequences 725-754 (nNOS) [8], 504-
532 (iNOS) [9] and 493-512 (eNOS) [10] (numbering based on 
positions within each NOS isoform). Secondly, there is the 
unique complexity of NOSs as homodimers [11,12]. Oligome-
rization may play a significant role not only for enzyme reg-
ulation but also for signal transduction. In the present study, 
we have defined the crucial amino acid cluster for C a M bind-
ing in nNOS using peptide chemistry studies and site-directed 
mutagenesis. 
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2. Materials and methods 
2.1. cDNA construction and mutagenesis 
A cDNA for rat brain nNOS was introduced into the EcoKl- and 
BamHI-digested pVL1393 transfer vector resulting in pVLnNOS. The 
EcoRl/BamHI fragment of the cDNA for the nNOS was inserted into 
M13mpl8 to produce single strand DNA for mutagenesis. Two differ-
ent oligonucleotides, 5'-CGCCTTGACCCTATCGGCCTCGGCCT-
GCCCCAT-3' and 5 ' -CTTGACGGCCTCTGCCTCATCATCAAA-
GCCGATAGCTCG-3', designed to provide mutations of (Met749/ 
Lys751) to (Glu749/Asp751) and (Lys732LysLeu) to (Asp732AspGlu) 
(underlined codons), respectively, were synthesized. The Amersham 
oligonucleotide-directed mutagenesis system (version 2.1) was used 
to generate mutant cDNAs. Mutant clones were isolated, and 
cDNA sequences were reconfirmed by dideoxynucleotide sequencing 
(Sequenase version 2.0, U.S. Biochem.). The mutant cDNAs were 
ligated into pVLnNOS and transfected into insect Sf9 cells. 
2.2. Purification of expressed nNOS protein 
Expression proteins in Sf9 cells and purification of expressed wild-
type or mutant nNOS on 2',5'-ADP-Sepharose were performed as 
described previously [13]. Protein concentrations were determined by 
the method of Bradford using BSA as the standard [14]. 
2.3. NOS enzymatic assays 
NOS activity of purified enzyme or cell lysates was assayed by 
measuring the conversion of L-[3 HJarginine to L-[3H]citrulline, as de-
scribed previously [2]. 
2.4. CaM-kinase la assays 
Assay conditions were 50 mM HEPES pH 7.5, 10 mM MgCl2, 
1 mM DTT, 100 uM [y-32P]ATP, 50 uM syntide-2, 1 uM CaM, 1 
mM CaCl2, and 300 nM recombinant CaM-kinase l a in a final vol-
ume of 20 ul at 30°C. The reaction was initiated by the addition of 
CaM-kinase la and terminated after 10 min by spotting aliquots (16 
jxl) onto phosphocellulose paper (Whatman P-81), followed by wash-
ing in 75 mM phosphoric acid. 
2.5. Gel electrophoresis and Western blot analysis 
One-dimensional SDS-PAGE was carried out according to the 
method of Laemmli [15]. The electrophoretic transfer of proteins 
from SDS-PAGE gels to PVDF membranes was performed as de-
scribed by Towbin et al. [16]. For immunodetection of the transferred 
proteins, the procedure of Burnette [17] was used except that the 
second antibody was linked to horseradish peroxidase. Antigen-anti-
body complexes were visualized by reacting the bound peroxidase 
with a chemiluminescence reagent (Du Pont). 
2.6. Gel mobility shift assays 
High affinity binding of peptides was analyzed by gel mobility shift 
assays of CaM on 1 M urea-15% polyacrylamide gels. Gels were run 
in the presence of either 0.1 mM CaCl2 or 2 mM EGTA in order to 
determine the Ca2+ dependence. 
2.7. CaM overlays 
Wild-type and mutant nNOS proteins were resolved on 7.5% SDS-
PAGE and electrophoretically transferred onto PVDF membranes. 
The membranes were blocked with 100 mM NaCl, 50 mM Tris (pH 
7.5), 1 mg/ml BSA, 0.05% Tween 20 in the presence of 1 mM CaCl2 
for 30 min at room temperature. Biotinylated CaM was then added at 
a final concentration of 0.5 ug/ml in Tris buffer followed by incuba-
tion for 30 min. After washing with the buffer, membranes were in-
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 0 1 2 - 4 
76 Y. Watanabe et al.lFEBS Letters 403 (1997) 75-78 
cubated with avidin-biotin-peroxidase (Vector Laboratories, Inc.), 
washed extensively, and then developed with the chemiluminescence 
reagent (Du Pont). 
2.8. Materials 
nNOS CaM binding peptide 23 (KKLAEAVKFSAKLMGQA-
MAKRVK), 16 (KFSAKLMGQAMAKRVK), and 12 (KLMGQA-
MAKRVK) were obtained from Nippon Shinyaku Co. (Kyoto, Ja-
pan). The cDNA for rat brain nNOS was a generous gift of Dr. 
Solomon H. Snyder (The Johns Hopkins University School of Med-
icine, Baltimore, MA). [y-32P]ATP (6000 Ci/mmol) was purchased 
from Dupont-New England Nuclear. L-[3H]Arginine and ECL detec-
tion kits were purchased from Amersham Corp. Restriction enzyme 
and DNA-modifying enzymes were from Takara Shuzo. 2',5'-ADP-
Sepharose was obtained from Pharmacia Biotec Inc. Electrophoresis 
reagents and the Bradford protein dye reagent were products of Bio-
Rad. Anti-nNOS antibody was from Transduction Laboratories (Lex-
ington, KY). All other materials and reagents were of the highest 
quality available from commercial suppliers. 
3. Results and discussion 
3.1. Identification of nNOS CaM binding sequence by gel 
mobility shift assays 
The CaM binding domain of rat brain nNOS was earlier 
identified to be formed by the sequence of amino acids 725-
754 (nNOS) [8] based on a computer search for hydrophobic-
ity, charge, and amphiphilic helical moment. For further stud-
ies of the CaM binding domain in nNOS, we initially synthe-
sized a 23 residue peptide (nNOS732_754 ; peptide 23) (Fig. 1) 
and tested its ability to produce an electrophoretic mobility 
shift of CaM on polyacrylamide gel electrophoresis in 1 M 
urea. In the presence of Ca2+, the electric mobility of CaM 
was retarded by peptide 23 (Fig. 1A), suggesting that it con-
tains residues necessary for binding of Ca2+/CaM by nNOS. 
Peptide 23, however, did not form a complex with CaM in the 
presence of EGTA, indicating the complex formation to be 
Ca2+ dependent (Fig. IB). The sequence was next shortened 
in the COOH-terminal direction to make a 16 residue 
(nNOS739_754 ; peptide 16) and a 12 residue peptide 
(nNOS743_754 ; peptide 12) (Fig. 1) for determination of spe-
cific amino acid residues critical for CaM binding. No com-
plex formation was detected with either in the presence of 
Ca2+ even at a 3:1 molar ratio of peptide to CaM (Fig. 1A). 
3.2. Inhibition of CaM-dependent enzyme activity by nNOS 
peptides 
We tested nNOS peptides as inhibitors of NOS enzyme 
activity using L-[3H]arginine as the substrate. As shown in 
Fig. 2A, peptide 23 strongly inhibited recombinant nNOS 
activity with an IC50 of about 1 uM. The concentration (0.1 
uM) of CaM was chosen to be more than sufficient for acti-
vation of NOS (data not shown) to ensure that inhibition 
would be seen if the mechanism was competition with CaM. 
Indeed, increasing the concentration of CaM resulted in a 
decrease in the inhibitory action of peptide 23 (data not 
shown), while increasing the concentration of substrate did 
not affect NOS activity (Fig. 2B). Neither peptide 12 nor 
peptide 16 showed any significant effects on NOS enzyme 
activity at the 0.1 \iM concentration of CaM (Fig. 2A). To 
assess the inhibition by peptide 23 of another CaM dependent 
enzyme, its effects on recombinant CaM-kinase la activity 
were determined. In the presence of Ca2+/CaM, peptide 23 
did inhibit CaM-kinase la with an IC50 (7 |xM) larger than 
its IC50 for nNOS (1 uM) (Fig. 2C). Peptides 12 and 16, in 
Fig. 1. Electrophoretic mobility shift of CaM by synthetic peptides. 
CaM (10 U.M) was incubated with the indicated synthetic peptide in 
the presence of 0.1 mM CaCl2 (A) or 2 mM EGTA (B). Samples 
were then electrophoresed on 1 M urea-15% polyacrylamide gels 
containing either 0.1 mM CaCl2 or 2 mM EGTA. The relative mo-
bilities of CaM and CaM-peptide complexes were visualized by 
Coomassie staining. Molar ratios of peptide:CaM of 0:1, 0.3:1, 1:1, 
and 3:1 are indicated. Note the mobility of CaM in the presence of 
CaCl2 is faster than that in the presence of EGTA without peptides. 
The sequences of the nNOS synthetic peptides are shown below the 
gels. Peptides were synthesized corresponding to the indicated 
nNOS sequence. 
contrast, did not show any significant influence at the 0.1 uM 
concentration of CaM (Fig. 2C). 
3.3. Identification of amino acids crucial for CaM binding 
In line with the concept that the hydrophobic/basic compo-
sition determining the propensity to form an amphiphilic helix 
is important for interaction with CaM, the above results in-
dicated that Lys732LysLeu in the nNOS are critical residues 
for CaM binding. To further investigate this hypothesis, we 
mutated two clusters of hydrophobic/basic residues in nNOS 
to produce a double mutant (Met749/Lys751 to Glu749/Asp751) 
and a triple mutant (Lys732LysLeu to Asp732AspGlu) (Table 
1). The specific activity of wild-type nNOS was 16.1 ±0.20 
nmol L-citrulline produced/min/mg protein, as determined by 
L-arginine to L-citrulline conversion. The double mutant 
showed significant loss of CaM activation (4.36 ±0.19 nmol 
L-citrulline produced/min/mg protein) and the triple mutant 
demonstrated a severe loss (Fig. 3), even with up to a 30:1 
molar excess of CaM (data not shown). The CaM binding of 
each mutant was significantly decreased as determined by the 
CaM gel overlay technique, with relative CaM binding affin-
ities were wild-type > double mutant > triple mutant (Fig. 3). 
This study used multiple approaches to identify the region 
of the nNOS that is involved in CaM binding. It was shown 
that the latch domain of CaM is an important interaction site 
which plays a critical role in nNOS activation [18]. Since 
peptide 23 did form a complex with CaM in the presence of 
Ca2+, the difference in IC50 between nNOS (1 uM) and CaM-
kinase la (7 uM) (Fig. 2) might be due to interaction with the 
latch domain of CaM. On the basis that the hydrophobic/ 
basic composition determining the propensity to form an am-
phiphilic helix is thought to be important for the interaction 
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Fig. 2. Effects of synthetic peptide derived from nNOS on CaM dependent enzyme activity. A: Effect of nNOS peptides on nNOS activity. Re-
combinant nNOS (100 nM) was assayed with 10 uM L-[3H]arginine, 0.1 uM CaM, 1 mM CaCl2, 10 uM BH4, 100 uM NADPH, and the indi-
cated concentrations of peptide 23 (o), peptide 16 (n), or peptide 12 ( A ) for 10 min at 30°C. The data were normalized to give percentages of 
the control value, defined as the total activity of NOS. B: Kinetic analysis of nNOS inhibition. Recombinant nNOS (100 nM) was assayed in 
either the presence (•) or the absence (o) of 10 uM peptide 23 under the same conditions as described in A with 3-100 uM L-[3H]arginine. C: 
Effect of nNOS peptides on CaM-kinase l a activity. Recombinant CaM-kinase l a (300 nM) was assayed with 50 |J,M syntide-2, 1 mM CaCi2, 
1 uM CaM, and the indicated concentrations of peptide 23 (o), peptide 16 (n), or peptide 12 ( A ) for 10 min at 30°C. The data are the means 
of two experiments. 
with C a M , we focused on the hydrophobic/basic cluster in 
nNOS732-754- The ÌNOS504-532 region has been identified as 
critical for C a M binding of murine iNOS [9]. Our results 
are similar to those described in the literature in that the 
eNOS493_512 peptides F498A, K499A, and L511A lost their 
capacity for high affinity binding of CaM, as evidenced by 
loss of C a M mobility shift on 4 M urea gels and significantly 
lower potencies for inhibition of eNOS than the wild-type 
peptide [10] (Table 1). Even though the specific hydropho-
bic/basic amino acid cluster critical for C a M binding by 
nNOS was identified in this study to be Lys732LysLeu, other 
hydrophobic/basic clusters within the n N O S sequence might 
also be important determinants of C a M binding, including 
Ala7 3 7ValLysPhe and Ala7 4 2LysLeuMet. The triple mutant 
of n N O S could be a useful molecular biological tool for 
studying the activation mechanism of nNOS, since this does 
not interfere with subunit interaction but should influence 
electron transfer through at least one subunit of the enzyme 
(Y. Watanabe and H. Hidaka, submitted). 
Table 1 
Alignment of putative CaM binding domains 
Triple Mutant Double Mutant 
732 749 
DDE E D 
M l I 
nNOS ( R a t ) KRRAIGFKKLAEAVKFSAKLMGQAMAKRVKATILYA 
n N O S ( H u m a n ) 
504 532 
i N O S ( H u m a n ) KRREIPLKVLVKAVLFACMLMRKTMASRVRVTTLFA 
i N O S ( M o u s e ) R - • • - R F R « • • . V » F « » S V A«VL« • 
eNOS ( H u m a n ) RKK TgKJEVANAVKISASgMGTVMAKRVKATILYG 
eNOS ( B o v i n e ) • • • L A 
The proposed CaM binding domains are for rat nNOS, bovine eNOS, 
and murine iNOS (solid dots denote identical residues). Amino acids 
determined to be critical for CaM binding are boxed [10]. Mutated 
Fig. 3. Enzyme activity of purified wild-type and mutant nNOS pro-
teins. Equivalent amounts (100 nM) of wild-type enzyme, double, 
and triple mutants were used and NOS activity was assayed by 
measuring the conversion of L-[3H]arginine to L-[3H]citrulline with 
10 uM L-[3H]arginine, 1 uM CaM, 1 mM CaCl2, 10 uM BH4, and 
100 uM NADPH for 10 min at 30°C. The data are the means of 
duplicate determinations from two experiments. The inset shows 
Coomassie (top), Western blot (middle), and CaM overlay (bottom) 
analyses of purified nNOS mutants. Lane 1, wild-type nNOS; lane 
2, double mutant nNOS; lane 3, triple mutant nNOS. Purified re-
combinant nNOS proteins including mutant enzymes (2 ug of each 
protein) were separated on 7.5% SDS-PAGE and analyzed by Coo-
massie blue staining, Western blotting with anti-nNOS, and reaction 
with biotinylated CaM in the presence of 1 mM CaCl2 as described 
in Section 2. 
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